Abbott Laboratories Expands Diagnostics Business
Abbott Laboratories is expanding its diagnostics operations, focusing on rapid and accurate testing solutions for various health conditions.
Abbott Laboratories, a global healthcare company, is deepening its commitment to diagnostics to enhance health management for individuals.
The company aims to provide timely and precise diagnostic information across core laboratory, molecular, and point-of-care testing. Abbott seeks to make testing solutions more accessible and improve healthcare efficiency worldwide, addressing significant global health challenges.
Abbott has established itself as a significant provider in areas such as COVID-19 testing and blood screening for transfusions. Its Alinity system is designed to increase laboratory throughput and improve workflow in a compact design, aiming for consistent, high-quality results.
Point-of-care testing is a key focus, delivering rapid results to physicians for timely treatment decisions in diverse settings. This includes testing for infectious diseases and other conditions, designed to improve patient care and clinical outcomes.
The company emphasizes the role of diagnostics in informed healthcare decisions and continues to develop technologies to help people live healthier lives.